Description
Click Therapeutics is at the forefront of modern medicine, merging neuroscience with software to develop patient-centric digital treatments. Their mission is to provide access to safe and effective prescription digital therapeutics that are evidence-based, clinically validated, and FDA regulated. Founded by David Benshoof Klein, Click Therapeutics aims to leverage software to improve clinical outcomes and bridge gaps in treatment access.
The company operates at the intersection of biology and technology, creating a new way to treat diseases through digital therapeutics. Their platform-based approach combines scientifically proven therapies with proprietary neuromodulatory mechanisms to deliver clinically meaningful interventions. Click Therapeutics develops software both for standalone use as prescription digital therapeutics (PDTs) and combination use as software-enhanced drugs (SE Drugs), each offering unique value.
Their digital therapies are delivered as mobile applications, regulated by the FDA and globally as medical devices. These treatments are prescribed by licensed healthcare professionals and are designed to treat diseases with digital mechanisms of action. Click Therapeutics' platform can target any disease, symptom, or side effect with an underlying neurological or behavioral component, enhancing the value of pharmacotherapy by supplementing efficacy, supporting adherence, or improving tolerability.
Click Therapeutics collaborates with pharmaceutical partners to develop and commercialize high-impact digital treatments. Their commitment to advancing research allows them to continually refine and expand their platform technologies, ensuring they stay at the forefront of cognitive, behavioral, and neuromodulatory therapeutic innovation. The company is supported by a strong investor base, including HIG, Accelmed, and Sanofi Ventures.
With a diverse team of clinicians, researchers, and technologists, Click Therapeutics is united in the mission to transform patient care. Their platform is backed by all required regulatory and quality controls, delivering consistent results and demonstrating evidence of safety and efficacy in robust randomized clinical trials.
Click Therapeutics's Core Features
Prescription digital therapeutics
Software-enhanced drug therapies
FDA-regulated mobile applications
Neuromodulatory mechanisms
Clinical trial validation
Collaborations with pharma partners
AI-enabled personalization
ISO 13485:2016 certified
How to use Click Therapeutics?
Download: Get the app from your healthcare provider
Consult: Discuss with your physician for prescription
Use: Follow the prescribed digital treatment
Monitor: Track progress and outcomes with the app
Click Therapeutics's Use Cases
- Major Depressive Disorder
- Episodic Migraine
- Schizophrenia
- Opioid Use Disorder
- Type 2 Diabetes